Washington, District of Columbia, United States
• Lead regulatory capital methodology and governance for counterparty credit risk related to the firm’s derivatives and securities financing transactions portfolio and clarify relevant regulatory capital treatment. • Establish firm regulatory capital frameworks and policy procedures and lead engagement with regulatory supervisors to secure alignment on policy implementation and procedural development. • Advise executive leadership on the impact of global capital frameworks to the derivatives and SFT portfolios, as well as the impact of Basel IV reforms to individual business lines. • Represent the firm in industry capital working groups to shape derivatives policy proposals and suggested reforms.
• Served as central point of expertise for regulatory capital implications of complex derivative transactions and relevant interpretive treatment proposals. Lead Barclays end-to-end policy implementation of SA-CCR framework • Delivered expert analysis on US regulatory capital requirements, advised on the application of RWA requirements, and engaged with regulatory supervisors on ad-hoc interpretive matters as well as routine bank examinations • Provided interpretation, impact and gap analysis of Basel IV proposed rulemaking in relation to existing business practice and structure and participate in industry discussions and advocacy efforts related to proposed framework • Engaged with internal and external stakeholders on emerging and developing policy areas
• Provided subject-matter expertise on regulatory capital interpretation and lead supervisory examinations on the implementation of regulatory standards such as SA-CCR, as well as monitoring and oversight of emerging risk areas • Produced briefing memos and data analysis on supervisory matters and regulatory requirements affecting U.S. Global Systemically Important Banks for governors, senior management, and supervisory teams • Performed aggregate impact analysis of major domestic and international events and regulatory developments such as Covid-19 Impact, Basel IV and SCB to firm capital levels, including RWA and TLE assessment • Serve as an FRS representative on the Basel Task Force on Evaluations, providing analysis on loss absorbency of capital instruments and validation of economic models assessing the effectiveness of Basel III during the Covid-19 pandemic • Participated in annual supervisory stress test as a member of the capital modeling team to ensure policy changes are implemented properly in the Board stress testing program and represent the stress test team in policy discussions
• Act as subject matter expert on regulatory matters such as capital treatment of financial instruments, regulatory changes issued by the Federal Reserve and BCBS, and providing support to stakeholders to ensure regulatory reforms are appropriately interpreted. • Conduct analysis and develop strategy on emerging issues and risk within the financial sector, including regulatory reform issues, and prepare presentations, briefing memoranda, and examiners’ guidance on regulatory capital developments as appropriate • Assess incremental capital action requests from all CCAR firms and monitor firm capital distributions to assist exam teams and other Supervision Group colleagues in their analyses on financial risk and capital adequacy • Assist with the interpretation and implementation of the Federal Reserve’s regulatory capital rules to assess regulatory reform proposals and associated supervisory implications for impacted firms in the Federal Reserve’s second district • Serve as the FRBNY representative to the Basel Leverage Ratio working group to assess regulatory standards across jurisdictions and generate monitoring reports on firm regulatory optimization under current framework
• Generated statistics on high frequency trading order types from FINRA market data using python for senior financial economists conducting research on market stability and order type variety • Assessed the benefits and efficacy of SEC rulemaking using STATA to compare panel data to analyze market trends of regulatory relief for firms following rule implementation • Analyzed structured data of prime fund investments to support study on impact of 2016 Money Market Fund Reform